Literature DB >> 16239109

Inflammation and prognosis in colorectal cancer.

Kai Klintrup1, Johanna M Mäkinen, Saila Kauppila, Päivi O Väre, Jukka Melkko, Hannu Tuominen, Karoliina Tuppurainen, Jyrki Mäkelä, Tuomo J Karttunen, Markus J Mäkinen.   

Abstract

AIM OF THE STUDY: Previous work has indicated that quantification of inflammatory cell reaction is of prognostic value in colorectal cancer. We evaluated the prognostic significance of inflammatory cell reaction patterns in colorectal cancer and developed a grading method which could be used in the routine assessment of tumours.
METHODS: The intensity of overall inflammatory cell reaction, numbers of neutrophilic and eosinophilic granulocytes, lymphoid cells and macrophages in both the central region and the invasive margin were estimated in 386 colorectal cancer patients. Prognostic significance was analysed by uni- and multivariate analysis.
RESULTS: Our method for classification of inflammatory reaction was reliable. High-grade inflammation at the invasive margin in Dukes' stage A and B cancers (pT1-2N0 and pT3N0, respectively) was associated with better 5-year-survival (87.6%) than low-grade inflammation (47.0%).
CONCLUSIONS: Inflammatory cell response at the invasive border is a relevant prognostic indicator and could be easily incorporated into the routine evaluation of histopathological specimens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239109     DOI: 10.1016/j.ejca.2005.07.017

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  142 in total

Review 1.  Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Authors:  Shona Hendry; Roberto Salgado; Thomas Gevaert; Prudence A Russell; Tom John; Bibhusal Thapa; Michael Christie; Koen van de Vijver; M V Estrada; Paula I Gonzalez-Ericsson; Melinda Sanders; Benjamin Solomon; Cinzia Solinas; Gert G G M Van den Eynden; Yves Allory; Matthias Preusser; Johannes Hainfellner; Giancarlo Pruneri; Andrea Vingiani; Sandra Demaria; Fraser Symmans; Paolo Nuciforo; Laura Comerma; E A Thompson; Sunil Lakhani; Seong-Rim Kim; Stuart Schnitt; Cecile Colpaert; Christos Sotiriou; Stefan J Scherer; Michail Ignatiadis; Sunil Badve; Robert H Pierce; Giuseppe Viale; Nicolas Sirtaine; Frederique Penault-Llorca; Tomohagu Sugie; Susan Fineberg; Soonmyung Paik; Ashok Srinivasan; Andrea Richardson; Yihong Wang; Ewa Chmielik; Jane Brock; Douglas B Johnson; Justin Balko; Stephan Wienert; Veerle Bossuyt; Stefan Michiels; Nils Ternes; Nicole Burchardi; Stephen J Luen; Peter Savas; Frederick Klauschen; Peter H Watson; Brad H Nelson; Carmen Criscitiello; Sandra O'Toole; Denis Larsimont; Roland de Wind; Giuseppe Curigliano; Fabrice André; Magali Lacroix-Triki; Mark van de Vijver; Federico Rojo; Giuseppe Floris; Shahinaz Bedri; Joseph Sparano; David Rimm; Torsten Nielsen; Zuzana Kos; Stephen Hewitt; Baljit Singh; Gelareh Farshid; Sibylle Loibl; Kimberly H Allison; Nadine Tung; Sylvia Adams; Karen Willard-Gallo; Hugo M Horlings; Leena Gandhi; Andre Moreira; Fred Hirsch; Maria V Dieci; Maria Urbanowicz; Iva Brcic; Konstanty Korski; Fabien Gaire; Hartmut Koeppen; Amy Lo; Jennifer Giltnane; Marlon C Rebelatto; Keith E Steele; Jiping Zha; Kenneth Emancipator; Jonathan W Juco; Carsten Denkert; Jorge Reis-Filho; Sherene Loi; Stephen B Fox
Journal:  Adv Anat Pathol       Date:  2017-11       Impact factor: 3.875

2.  Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial.

Authors:  Maria Di Bartolomeo; Federica Morano; Alessandra Raimondi; Rosalba Miceli; Salvatore Corallo; Elena Tamborini; Federica Perrone; Maria Antista; Monica Niger; Alessandro Pellegrinelli; Giovanni Randon; Filippo Pagani; Antonia Martinetti; Giovanni Fucà; Filippo Pietrantonio
Journal:  Oncologist       Date:  2019-11-25

3.  The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis.

Authors:  H H Tam; D J Collins; G Brown; I Chau; D Cunningham; M O Leach; D-M Koh
Journal:  Br J Radiol       Date:  2013-08-30       Impact factor: 3.039

4.  Clinical implications of the tumor-infiltrating lymphocyte subsets in colorectal cancer.

Authors:  Yunmei Liao; Juanjuan Ou; Jia Deng; Peiliang Geng; Rui Zeng; Yi Tian; Houjie Liang; Bing Ni; Zhihua Ruan
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

5.  Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial.

Authors:  Maria Di Bartolomeo; Federica Morano; Alessandra Raimondi; Rosalba Miceli; Salvatore Corallo; Elena Tamborini; Federica Perrone; Maria Antista; Monica Niger; Alessandro Pellegrinelli; Giovanni Randon; Filippo Pagani; Antonia Martinetti; Giovanni Fucà; Filippo Pietrantonio
Journal:  Oncologist       Date:  2019-11-25

6.  HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.

Authors:  Giuseppe Sconocchia; Serenella Eppenberger-Castori; Inti Zlobec; Eva Karamitopoulou; Roberto Arriga; Andrea Coppola; Sara Caratelli; Giulio Cesare Spagnoli; Davide Lauro; Alessandro Lugli; Junyi Han; Giandomenica Iezzi; Cristina Ferrone; Amedeo Ferlosio; Luigi Tornillo; Raoul Droeser; Piero Rossi; Antonio Attanasio; Soldano Ferrone; Luigi Terracciano
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

7.  Programmed death ligand-1 expression in non-small cell lung cancer.

Authors:  Vamsidhar Velcheti; Kurt A Schalper; Daniel E Carvajal; Valsamo K Anagnostou; Konstantinos N Syrigos; Mario Sznol; Roy S Herbst; Scott N Gettinger; Lieping Chen; David L Rimm
Journal:  Lab Invest       Date:  2013-11-11       Impact factor: 5.662

8.  Activated systemic inflammatory response at diagnosis reduces lymph node count in colonic carcinoma.

Authors:  Rory P Kennelly; Brenda Murphy; John O Larkin; Brian J Mehigan; Paul H McCormick
Journal:  World J Gastrointest Oncol       Date:  2016-08-15

Review 9.  Cancer and inflammation.

Authors:  Lance L Munn
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-12-12

10.  Polymorphisms of the ICAM-1 exon 6 (E469K) are associated with differentiation of colorectal cancer.

Authors:  Qing-lei Wang; Bing-hui Li; Bin Liu; Ya-bin Liu; Yue-Ping Liu; Sui-Bing Miao; Yi Han; Jin-Kun Wen; Mei Han
Journal:  J Exp Clin Cancer Res       Date:  2009-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.